Charlotte De Bondt

Edegem, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial.

Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial.

Journal: Lancet (London, England)

Published: January 20, 2025

Tepotinib Plus an EGFR Tyrosine Kinase Inhibitor in Patients With EGFR-Mutant MET-Altered NSCLC: A Case Series.

Tepotinib Plus an EGFR Tyrosine Kinase Inhibitor in Patients With EGFR-Mutant MET-Altered NSCLC: A Case Series.

Journal: Clinical lung cancer

Published: October 28, 2024

Pseudo-acute kidney injury secondary to tepotinib.

Pseudo-acute kidney injury secondary to tepotinib.

Journal: Clinical kidney journal

Published: June 15, 2022

New Implications of Patients' Sex in Today's Lung Cancer Management.

New Implications of Patients' Sex in Today's Lung Cancer Management.

Journal: Cancers

Published: May 06, 2022

Multimodality Treatment including Surgery Related to the Type of N2 Involvement in Locally Advanced Non-Small Cell Lung Cancer.

Multimodality Treatment including Surgery Related to the Type of N2 Involvement in Locally Advanced Non-Small Cell Lung Cancer.

Journal: Cancers

Published: February 22, 2022

Correction: A Flare for the Unexpected: Bone Flare as Response to Tyrosine Kinase Inhibitor Treatment in a Lung Cancer Patient.

Correction: A Flare for the Unexpected: Bone Flare as Response to Tyrosine Kinase Inhibitor Treatment in a Lung Cancer Patient.

Journal: Journal of the Belgian Society of Radiology

Published: June 23, 2020

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Published: May 26, 2020

A Flare for the Unexpected: Bone Flare as Response to Tyrosine Kinase Inhibitor Treatment in a Lung Cancer Patient: New osteoblastic bone lesions in a lung cancer patient may represent bone flare and should not be misdiagnosed as disease progression.

A Flare for the Unexpected: Bone Flare as Response to Tyrosine Kinase Inhibitor Treatment in a Lung Cancer Patient: New osteoblastic bone lesions in a lung cancer patient may represent bone flare and should not be misdiagnosed as disease progression.

Journal: Journal of the Belgian Society of Radiology

Published: May 08, 2020

Cancer in the time of COVID-19: expert opinion on how to adapt current practice.

Cancer in the time of COVID-19: expert opinion on how to adapt current practice.

Journal: The European respiratory journal

Published: April 01, 2020

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.

Journal: The European respiratory journal

Published: May 12, 2019

Combined modality treatment in mesothelioma: a systemic literature review with treatment recommendations.

Combined modality treatment in mesothelioma: a systemic literature review with treatment recommendations.

Journal: Translational lung cancer research

Published: November 20, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026